Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis
- PMID: 24578595
- PMCID: PMC3936241
- DOI: 10.1016/j.jsha.2013.08.003
Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis
Abstract
Background: Current published literature on hypertrophic cardiomyopathy (HCM) comes primarily from Western populations. There is no published data on clinical and echocardiographic characteristics and long-term outcome of HCM in an Arab population.
Methods: We conducted a retrospective analysis of all patients 16 years or older diagnosed with HCM at our institution. Detailed clinical and echocardiographic data were collected and outcome was analyzed.
Results: A total of 69 patients were identified as having HCM. The mean age was 42 ± 16 years with 71% male patients. All patients were Saudi citizens with Arab ancestry. Details about family history and presenting symptoms were available for 44 and 48 patients consecutively. Nine (18%) patients were asymptomatic and were diagnosed based on abnormal cardiac auscultation. The commonest presenting symptoms were dyspnea with or without chest pain and palpitations occurring in 40 (81%) patients. Only four (9%) of 44 patients had a family history of HCM and /or sudden cardiac death (SCD). The most common ECG abnormality was left ventricular hypertrophy (LVH) present in 60 (86%) patients. The commonest septal hypertrophy morphology was mid-septal (catenoid) in 30 (43%) followed by neutral in 23 (33%), basal septal (sigmoid) in 3 (4%) and apical in 6 (8%) patients. Twenty (28%) patients had evidence of resting left ventricular cavity gradient of ⩾30 mmHg. Eleven (16%) patients had evidence of biventricular hypertrophy. Left ventricular ejection fraction was normal in 65 (94%) patients. Over a median (25-75 percentile) follow-up of 7 years (4.5-10), only three patients died, all of non-cardiac causes. There were no cases of SCD during the follow-up period. Six patients required an implantable cardioverter-defibrillator (ICD); five for primary prevention and one for secondary prevention. Only one patient progressed to end stage dilated cardiomyopathy.
Conclusion: The natural history of hypertrophic cardiomyopathy in the Saudi population appears to be benign with catenoid morphology being the most common septal hypertrophy pattern. Risk of SCD appears to be quite low in this population.
Keywords: Echocardiography; Hypertrophic cardiomyopathy; Outcome; Septal morphology.
Figures





Similar articles
-
Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy.Eur J Echocardiogr. 2011 Feb;12(2):131-9. doi: 10.1093/ejechocard/jeq163. Epub 2010 Nov 1. Eur J Echocardiogr. 2011. PMID: 21044981
-
Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience.Pediatr Int. 2021 Jan;63(1):37-45. doi: 10.1111/ped.14393. Epub 2020 Dec 5. Pediatr Int. 2021. PMID: 32682351
-
Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention.BMC Cardiovasc Disord. 2021 Feb 19;21(1):106. doi: 10.1186/s12872-021-01910-0. BMC Cardiovasc Disord. 2021. PMID: 33607967 Free PMC article.
-
[ALPK3 gene-related pediatric cardiomyopathy with craniofacial-skeletal features: a report and literature review].Zhonghua Er Ke Za Zhi. 2021 Sep 2;59(9):787-792. doi: 10.3760/cma.j.cn112140-20210222-00150. Zhonghua Er Ke Za Zhi. 2021. PMID: 34645221 Review. Chinese.
-
Management of hypertrophic cardiomyopathy.Ann Glob Health. 2014 Jan-Feb;80(1):35-45. doi: 10.1016/j.aogh.2013.12.004. Epub 2013 Dec 25. Ann Glob Health. 2014. PMID: 24751563 Review.
Cited by
-
Long term mortality in patients with hypertrophic cardiomyopathy - A Danish nationwide study.Am Heart J Plus. 2022 Dec 22;25:100244. doi: 10.1016/j.ahjo.2022.100244. eCollection 2023 Jan. Am Heart J Plus. 2022. PMID: 38510499 Free PMC article.
-
Hypertrophic Cardiomyopathy in Saudi Arabia: A Systematic Review of the Epidemiological, Clinical, and Imaging Features.Curr Cardiol Rev. 2023;19(2):e250822208003. doi: 10.2174/1573403X18666220825153725. Curr Cardiol Rev. 2023. PMID: 36028969 Free PMC article.
-
Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.Cardiovasc J Afr. 2016 May/Jun;27(3):152-158. doi: 10.5830/CVJA-2015-075. Cardiovasc J Afr. 2016. PMID: 27841901 Free PMC article.
-
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy.Circ Arrhythm Electrophysiol. 2025 Feb;18(2):e013479. doi: 10.1161/CIRCEP.124.013479. Epub 2025 Feb 3. Circ Arrhythm Electrophysiol. 2025. PMID: 39895487 Free PMC article.
References
-
- Maron B.J. Hypertrophic cardiomyopathy: an important global disease. Am J Med. 2004;116:63–65. - PubMed
-
- Zou Y., Song L., Wang Z. Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. Am J Med. 2004;116:14–18. - PubMed
-
- Maron B.J., Gardin J.M., Flack J.M. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study coronary artery risk development in (young) adults. Circulation. 1995;92:785–789. - PubMed
-
- Cannan C.R., Reeder G.S., Bailey K.R. Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation. 1995;92:2488–2495. - PubMed
-
- Cecchi F., Olivotto I., Montereggi A. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol. 1995;26:1529–1536. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources